Inhibition of Toll-like Receptor-4 expression for amelioration of myocardial injury in diabetes: A meta-analysis. Clinics, [S. l.], v. 77, p. 100137, 2022. DOI: 10.1016/j.clinsp.2022.100137. Disponível em: https://revistas.usp.br/clinics/article/view/213611.. Acesso em: 1 jun. 2024.